Sorrento has another great day - lifts COVID VACCINE STOCKS to modest gains.

Sorrento leads the way up again with a solid 14% gain based on good clinical results with anti-body therapy clinical work with hamsters.

Tonix, NNVC and GeoVax also had solid gains, up 6.3%, 5.3% and 5.2% respectively. The latter has a market value of less than $3M after some additional stock offerings and a reverse split.

Overall, 16 stocks were up with 11 down and an average gain of 1.4%.